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Gene	 Missense	 PTV	 P-value	 Test	 Clustering	
CDK13	 10	 1	 3.2	x	10
-19
	 DDD	 Yes	
GNAI1	 7	(1)	 1	 2.1	x	10
-13
	 DDD	 No	
CSNK2A1	 7	 0	 1.4	x	10
-12
	 DDD	 Yes	
PPM1D	 0	 5	(1)	 6.3	x	10
-12
	 Meta	 No	
CNOT3	 5	 2	(1)	 5.2	x	10
-11
	 DDD	 Yes	
MSL3	 0	 4	 2.2	x	10
-10
	 DDD	 No	
KCNQ3	 4	(3)	 0	 3.4	x	10
-10
	 Meta	 Yes	
ZBTB18	 1	(1)	 4	 1.4	x	10
-9
	 DDD	 No	
PUF60	 4	(1)	 3	 2.6	x	10
-9
	 DDD	 No	
TCF20	 1	 5	 2.7	x	10
-9
	 DDD	 No	
SUV420H1	 0	(2)	 2	(3)	 2.9	x	10
-9
	 Meta	 No	
CHD4	 8	(1)	 1	 7.6	x	10
-9
	 DDD	 No	
SET	 0	 3	 1.2	x	10
-7
	 DDD	 No	
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Supplementary	Table	2:	Details	of	cohorts	used	in	meta-analyses.	This	includes	numbers	of	individuals	by	sex	and	publication	details.	
Phenotype	 Year	 Male	 Female	 Note	 Citation	
Intellectual	disability	 2012	 47	 53	 	 De	Ligt,	et	al.	
3
	










Intellectual	disability	 2012	 19	 32	 	 Rauch,	et	al.	
12
	














Congenital	heart	disease	 2013	 220	 142	 	 Zaidi,	et	al.	
14
	





Schizophrenia	 2014	 308	 317	 	 Fromer,	et	al.	
7
	











Autism	spectrum	disorder	 2014	 446	 112	 Probands	with	IQ	<	70.	 Iossifov,	et	al.	
9
	







































































































































































0.6 0.8 1.0 1.2 1.4
assisted reproduction P = 0.584
abnormal scan P = 0.071
bleeding P = 0.346
feeding problems
male sex




























































































































































































































Mutations Growth Development Clinical features





























0.98 1.82 0.88 1.93
-0.62 -1.15 -0.09 -0.66
-0.73 -2.36 -1.88 -3.6
-0.73 -1.47 -0.17 0.59
0.3 0.24 0.11 -2.96
0.75 -0.75 -0.66 -2.73
-1.37 -2.64 -2.55 -2.53
0.07 0.87 1.06 -0.33
-0.82 -2.66 -1.89 -1.59
-0.34 -1.82 -0.99 -0.78
0.53 -0.98 -0.4 -2.57
-0.06 -1.43 -0.92 -2.18
-0.87 -0.37 0.24 -0.15





























4 0 2 0 2 0 0
2 0 0 0 2 2 0
3 0 7 2 4 0 0
6 0 2 0 4 0 0
3 0 0 0 5 0 0
4 0 0 5 5 0 0
8 0 13 2 6 5 2
7 0 5 2 11 2 0
11 2 10 4 6 2 4
10 0 13 4 12 2 2
16 0 11 2 12 0 2
14 0 4 4 10 0 0
14 11 7 3 10 3 4
36 13 18 10 22 3 0














































Relative cost of exome to genome














































































Proportion of missense as loss-of-function
























































































































































































































































0.24 0.26 0.28 0.29 0.31 0.33 0.35 0.37 0.39
0.25 0.27 0.29 0.31 0.32 0.34 0.36 0.38 0.40
0.26 0.28 0.30 0.32 0.34 0.35 0.37 0.39 0.41
0.27 0.29 0.31 0.33 0.35 0.36 0.38 0.40 0.42
0.28 0.30 0.32 0.34 0.36 0.38 0.39 0.41 0.43
0.29 0.31 0.33 0.35 0.37 0.39 0.40 0.42 0.44
0.30 0.32 0.34 0.36 0.38 0.40 0.42 0.43 0.45
0.31 0.33 0.35 0.37 0.39 0.41 0.43 0.45 0.46














































































































































































STXBP1 11 7 4 6 5 0.31 -0.17 0.85 -0.35 2 11 27 48 0 0 3 0 15 3 0 STXBP1






























































































probands (n) Z-score delayed development terms (n)


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































17 44 8 0
0 0
00199
0 13 7 23 8 6
0 14 6 15 0 5
0 14 0 18 0 0
0 0 5 13 0 0
0 5 5 14 0 0
0 4 0 14 0 0
5
9
0 4 0 15 0 0
0 6 0 18 4 0
4 0 12 5 12 6 9
0 0 5 4 8 4 12
18 0 6 4 20 4 0
36 13 18 10 22 3 0
11 0 13 3 19 7 4
0 0 6 0 19 0 3
19 3 9 3 10 6 0
10 0 0 0 15 0 4
4 0 0 0 19 3 0
14 0 3 0 10 0 0
9 3 17 3 16 0 3
3 0 3 3 8 0 6
0 0 0 0 9 0 0
14 0 9 3 21 3 0
3 5 9 3 10 0 0
4 0 3 0 8 0 0
0 0 8 3 9 0 0
9 0 0 3 8 4 0
0 0 0 0 9 0 0
14 11 7 3 10 3 4
7 0 6 4 7 0 0
0 0 4 11 3 04
0 0 0 0 13 0 0
02100604
14 0 4 4 10 0 0
2012211016
0 0 0 0 8 0 0
0293507
10 0 7 0 0 2 2
0470002
2 0 4 0 0 4 2
001239510
3 0 2 0 8 6 0
221210 0 13 4
2 2 2 0 4 0 0
2 0 5 0 0 0 0
5 0 3 0 11 2 0
13 0 0 0 10 2 0
2 0 3 2 4 2 0
4 0 4 0 15 2 0
5 0 0 0 8 2 0
11 2 10 4 6 2 4
4 0 0 0 6 0 0
7 0 5 2 11 2 0
2 0 3 0 8 0 0
5 0 0 0 5 0 0
3 0 2 0 0 0 0
4 0 0 0 5 0 0
14 2 5 4 4 0 2
0 0 0 0 0 0 0
4 0 2 0 0 0 0
0 0 3 0 6 0 0
2 0 5 0 4 4 0
5 0 8 3 4 0 0
2 0 0 2 5 0 2
8 0 13 2 6 5 2
4 0 0 5 5 0 0
0 0 0 0 0 0 0
0000000
2 0 0 2 5 0 2
0050003
6 0 2 0 4 0 0
0042402
6 0 2 0 3 0 0
101
3 0 0 2 3 2 0
2 0 8 2 3 0 0
4 0 2 0 8 2 0
4 0 2 0 4 0 0
0 0 0 0 2 0 0
0 0 0 0 3 0 0
0 0 0 0 0 0 0
2 0 2 0 2 0 0
0 0 0 0 0 0 0
0 0 0 0 0 0 0
3 0 4 0 3 0 0
0 0 0 0 2 0 0
2 0 0 0 2 0 0
4 0 2 0 2 0 0
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relative cost of exome to genome















































































































0.86 0.90 0.94 0.98
threshold:0.00781
A B
